These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

150 related items for PubMed ID: 10363175

  • 1. Increased level of serum hepatocyte growth factor/scatter factor in liver cancer is associated with tumor metastasis.
    Junbo H, Li Q, Zaide W, Yunde H.
    In Vivo; 1999; 13(2):177-80. PubMed ID: 10363175
    [Abstract] [Full Text] [Related]

  • 2. Significance of serum hepatocyte growth factor levels in patients with hepatocellular carcinoma undergoing hepatic resection.
    Chau GY, Lui WY, Chi CW, Chau YP, Li AF, Kao HL, Wu CW.
    Eur J Surg Oncol; 2008 Mar; 34(3):333-8. PubMed ID: 17218078
    [Abstract] [Full Text] [Related]

  • 3. Evaluation of interleukin-6, interleukin-10 and human hepatocyte growth factor as tumor markers for hepatocellular carcinoma.
    Hsia CY, Huo TI, Chiang SY, Lu MF, Sun CL, Wu JC, Lee PC, Chi CW, Lui WY, Lee SD.
    Eur J Surg Oncol; 2007 Mar; 33(2):208-12. PubMed ID: 17140760
    [Abstract] [Full Text] [Related]

  • 4. Serum concentrations of human hepatocyte growth factor is a useful indicator for predicting the occurrence of hepatocellular carcinomas in C-viral chronic liver diseases.
    Yamagamim H, Moriyama M, Matsumura H, Aoki H, Shimizu T, Saito T, Kaneko M, Shioda A, Tanaka N, Arakawa Y.
    Cancer; 2002 Aug 15; 95(4):824-34. PubMed ID: 12209727
    [Abstract] [Full Text] [Related]

  • 5. Serum hepatocyte growth factor before and after resection for hepatocellular carcinoma.
    Hu RH, Lee PH, Yu SC, Sheu JC, Lai MY.
    Hepatogastroenterology; 1999 Aug 15; 46(27):1842-7. PubMed ID: 10430357
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Vascular endothelial growth factor expression in serum of patients with hepatocellular carcinoma.
    Zhao J, Hu J, Cai J, Yang X, Yang Z.
    Chin Med J (Engl); 2003 May 15; 116(5):772-6. PubMed ID: 12875699
    [Abstract] [Full Text] [Related]

  • 10. Clinical significance of serum HGF and c-Met expression in tumor tissue for evaluation of properties and treatment of hepatocellular carcinoma.
    Osada S, Kanematsu M, Imai H, Goshima S.
    Hepatogastroenterology; 2008 May 15; 55(82-83):544-9. PubMed ID: 18613405
    [Abstract] [Full Text] [Related]

  • 11. [Significance of vascular endothelial growth factor expression in serum of patients with hepatocellular carcinoma].
    Zhao J, Hu J, Cai J.
    Zhonghua Zhong Liu Za Zhi; 2001 Sep 15; 23(5):389-92. PubMed ID: 11810769
    [Abstract] [Full Text] [Related]

  • 12. Quantitative analysis of vascular endothelial growth factor, microvascular density and their clinicopathologic features in human hepatocellular carcinoma.
    Yao DF, Wu XH, Zhu Y, Shi GS, Dong ZZ, Yao DB, Wu W, Qiu LW, Meng XY.
    Hepatobiliary Pancreat Dis Int; 2005 May 15; 4(2):220-6. PubMed ID: 15908319
    [Abstract] [Full Text] [Related]

  • 13. Effects of human hepatocyte growth factor on the proliferation of human hepatocytes and hepatocellular carcinoma cell lines.
    Efimova EA, Glanemann M, Liu L, Schumacher G, Settmacher U, Jonas S, Langrehr JM, Neuhaus P, Nüssler AK.
    Eur Surg Res; 2004 May 15; 36(5):300-7. PubMed ID: 15359093
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Serum hepatocyte growth factor levels in liver diseases: clinical implications.
    Shiota G, Okano J, Kawasaki H, Kawamoto T, Nakamura T.
    Hepatology; 1995 Jan 15; 21(1):106-12. PubMed ID: 7806142
    [Abstract] [Full Text] [Related]

  • 16. High serum vascular endothelial growth factor levels predict poor prognosis after radiofrequency ablation of hepatocellular carcinoma: importance of tumor biomarker in ablative therapies.
    Poon RT, Lau C, Pang R, Ng KK, Yuen J, Fan ST.
    Ann Surg Oncol; 2007 Jun 15; 14(6):1835-45. PubMed ID: 17406950
    [Abstract] [Full Text] [Related]

  • 17. Serum human hepatocyte growth factor (hHGF) is elevated in patients with metastatic gastric carcinoma.
    Niki M, Isozaki H, Toyoda M, Ishibashi T, Fujii K, Nomura E, Mabuchi H, Nakamura M, Nishiguchi K, Tanigawa N.
    Hepatogastroenterology; 1999 Jun 15; 46(25):568-73. PubMed ID: 10228863
    [Abstract] [Full Text] [Related]

  • 18. Hepatocyte growth factor and acute phase proteins in patients with chronic liver diseases.
    Shiota G, Umeki K, Okano J, Kawasaki H.
    J Med; 1995 Jun 15; 26(5-6):295-308. PubMed ID: 8721905
    [Abstract] [Full Text] [Related]

  • 19. Predictive value of plasma hepatocyte growth factor/scatter factor levels in patients with clinically localized prostate cancer.
    Gupta A, Karakiewicz PI, Roehrborn CG, Lotan Y, Zlotta AR, Shariat SF.
    Clin Cancer Res; 2008 Nov 15; 14(22):7385-90. PubMed ID: 19010854
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.